Drug intelligence / Profile preview

Liujun Anwei

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Liujun Anwei is a traditional Chinese medicine (TCM) herbal formula used primarily for gastrointestinal disorders. It is a multi-herb combination designed to strengthen the spleen and stomach, harmonize the middle burner (digestive system), and alleviate symptoms such as poor appetite, bloating, nausea, and indigestion. The formula typically contains herbs like Codonopsis pilosula (Dang Shen), Atractylodes macrocephala (Bai Zhu), Poria cocos (Fu Ling), Glycyrrhiza uralensis (Gan Cao), Pinellia ternata (Ban Xia), Citrus reticulata peel (Chen Pi), among others. Its mechanism of action involves modulation of inflammatory pathways and regulation of digestive function through multiple targets; network pharmacology studies suggest involvement with targets such as AKT1, TP53, TNF-alpha, and IL-17 signaling pathways[1]. It is not a single pharmaceutical compound but rather a complex mixture characteristic of TCM practice.

Brand names: Liujun Anwei
Other names: Liujun Anwei decoctionLiujun Wan六君安胃六君子安胃

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)TNFA (Tumor necrosis factor alpha (soluble))IL-17R (Interleukin 17 Receptor)

Beyond the preview

Go deeper on Liujun Anwei.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liujun Anwei.

Explore the full profile